Edoxaban
- 7 March 2014
- journal article
- review article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 19 (5), 409-416
- https://doi.org/10.1177/1074248414523675
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 34 references indexed in Scilit:
- An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary SyndromesJournal of the American Heart Association, 2013
- Venous thromboembolism: Epidemiology and magnitude of the problemBest Practice & Research Clinical Haematology, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- New Antithrombotic DrugsChest, 2012
- In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinuxThrombosis Research, 2011
- EdoxabanDrugs, 2011
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillationThrombosis and Haemostasis, 2010
- DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profilesJournal of Thrombosis and Haemostasis, 2008
- Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamberThrombosis and Haemostasis, 2007
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005